-
1
-
-
0029963359
-
Designing cross-sectional pharmacokinetic studies: Implications for pediatric and animal studies
-
Jones CD, Sun H, Ette EI: Designing cross-sectional pharmacokinetic studies: implications for pediatric and animal studies. Clin Res Reg Affairs 1996;13:133-165.
-
(1996)
Clin Res Reg Affairs
, vol.13
, pp. 133-165
-
-
Jones, C.D.1
Sun, H.2
Ette, E.I.3
-
3
-
-
0030430243
-
On error in the recording of sampling times and parameter estimation from repeated measures pharmacokinetic data
-
Sun H, Ette EI, Ludden TM: On error in the recording of sampling times and parameter estimation from repeated measures pharmacokinetic data. J Pharmacokinet Biopharm 1996;24:635-648.
-
(1996)
J Pharmacokinet Biopharm
, vol.24
, pp. 635-648
-
-
Sun, H.1
Ette, E.I.2
Ludden, T.M.3
-
4
-
-
0004062826
-
-
Los Angeles, CA: Biomedical Simulation Resource, University of Southern California, Los Angeles
-
D'Argenio DZ, Schumitzky A: ADAPTII User's Guide. Los Angeles, CA: Biomedical Simulation Resource, University of Southern California, Los Angeles, 1992.
-
(1992)
ADAPTII User's Guide
-
-
D'Argenio, D.Z.1
Schumitzky, A.2
-
5
-
-
0002255250
-
Design of experiments for estimating enzyme and pharmacokinetic experiments
-
Endrenyi L (ed.) New York: Plenum Press
-
Endrenyi L: Design of experiments for estimating enzyme and pharmacokinetic experiments. In, Endrenyi L (ed.): Kinetic Data Analysis of Enzyme and Pharmacokinetic Experiments. New York: Plenum Press, 1981;137-167.
-
(1981)
Kinetic Data Analysis of Enzyme and Pharmacokinetic Experiments
, pp. 137-167
-
-
Endrenyi, L.1
-
6
-
-
0003167589
-
Simulation of clinical trials: Encouragement and cautions
-
Peck CC, Desjardins RE: Simulation of clinical trials: encouragement and cautions (editorial). Appl Clin Trials 1996;5: 31-32.
-
(1996)
Appl Clin Trials
, vol.5
, pp. 31-32
-
-
Peck, C.C.1
Desjardins, R.E.2
-
7
-
-
0002002390
-
Clinical trial simulation: Streamlining your drug development process
-
Hale M, Gillespie WR, Gupta SK, Tuk B, Holford NHG: Clinical trial simulation: streamlining your drug development process. Appl Clin Trials 1996;5:35-40.
-
(1996)
Appl Clin Trials
, vol.5
, pp. 35-40
-
-
Hale, M.1
Gillespie, W.R.2
Gupta, S.K.3
Tuk, B.4
Holford, N.H.G.5
-
8
-
-
0003100554
-
Robustness in the strategy of scientific model building
-
Launer RL, Wilkinson GN (eds.) New York: Academic Press
-
Box GEP: Robustness in the strategy of scientific model building. In, Launer RL, Wilkinson GN (eds.): Robustness in Statistics. New York: Academic Press, 1979;201-236.
-
(1979)
Robustness in Statistics
, pp. 201-236
-
-
Box, G.E.P.1
-
9
-
-
0029621202
-
Population pharmacokinetic modeling: The importance of informative graphics
-
Ette EI, Ludden TM: Population pharmacokinetic modeling: the importance of informative graphics. Pharm Res 1995;12:1845-1855.
-
(1995)
Pharm Res
, vol.12
, pp. 1845-1855
-
-
Ette, E.I.1
Ludden, T.M.2
|